165 related articles for article (PubMed ID: 35173288)
1. Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients.
Ogimi C; Xie H; Waghmare A; Jerome KR; Leisenring WM; Ueda Oshima M; Carpenter PA; Englund JA; Boeckh M
Bone Marrow Transplant; 2022 Apr; 57(4):649-657. PubMed ID: 35173288
[TBL] [Abstract][Full Text] [Related]
2. Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients.
Ogimi C; Xie H; Waghmare A; Jerome KR; Leisenring WM; Milano F; Englund JA; Boeckh M
J Clin Virol; 2022 Jun; 150-151():105152. PubMed ID: 35447514
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation.
Ogimi C; Xie H; Waghmare A; Ueda Oshima M; Mallhi KK; Jerome KR; Leisenring WM; Englund JA; Boeckh M
Blood Adv; 2021 Apr; 5(7):1903-1914. PubMed ID: 33792629
[TBL] [Abstract][Full Text] [Related]
5. Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection.
Waghmare A; Xie H; Kuypers J; Sorror ML; Jerome KR; Englund JA; Boeckh M; Leisenring WM
Biol Blood Marrow Transplant; 2019 May; 25(5):1011-1021. PubMed ID: 30537551
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
[TBL] [Abstract][Full Text] [Related]
7. Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
Waghmare A; Xie H; Kimball L; Yi J; Özkök S; Leisenring W; Cheng GS; Englund JA; Watkins TR; Chien JW; Boeckh M
J Infect Dis; 2017 Dec; 216(10):1235-1244. PubMed ID: 28961971
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
Houist AL; Bondeelle L; Salmona M; LeGoff J; de Latour RP; Rivière F; Soler C; Houdouin V; Dalle JH; Robin C; Fourati S; Griscelli F; Coman T; Chevret S; Bergeron A
Bone Marrow Transplant; 2021 Dec; 56(12):3032-3041. PubMed ID: 34548625
[TBL] [Abstract][Full Text] [Related]
9. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.
Shah DP; Ghantoji SS; Ariza-Heredia EJ; Shah JN; El Taoum KK; Shah PK; Nesher L; Hosing C; Rondon G; Champlin RE; Chemaly RF
Blood; 2014 May; 123(21):3263-8. PubMed ID: 24700783
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients.
Ogimi C; Krantz EM; Golob JL; Waghmare A; Liu C; Leisenring WM; Woodard CR; Marquis S; Kuypers JM; Jerome KR; Pergam SA; Fredricks DN; Sorror ML; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2293-2301. PubMed ID: 29777867
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation.
Boonyaratanakornkit J; Vivek M; Xie H; Pergam SA; Cheng GS; Mielcarek M; Hill JA; Jerome KR; Limaye AP; Leisenring W; Boeckh MJ; Waghmare A
J Infect Dis; 2020 Jan; 221(3):379-388. PubMed ID: 31541573
[TBL] [Abstract][Full Text] [Related]
12. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.
Martino R; Porras RP; Rabella N; Williams JV; Rámila E; Margall N; Labeaga R; Crowe JE; Coll P; Sierra J
Biol Blood Marrow Transplant; 2005 Oct; 11(10):781-96. PubMed ID: 16182179
[TBL] [Abstract][Full Text] [Related]
14. The impact of pre-transplant respiratory virus detection on post-transplant outcomes in children undergoing hematopoietic cell transplantation.
Kim SR; Nordlander A; Xie H; Kim YJ; Ogimi C; Thakar MS; Leisenring W; Englund JA; Boeckh M; Waghmare A
Clin Infect Dis; 2024 Apr; ():. PubMed ID: 38666501
[TBL] [Abstract][Full Text] [Related]
15. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF
Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.
Kim YJ; Guthrie KA; Waghmare A; Walsh EE; Falsey AR; Kuypers J; Cent A; Englund JA; Boeckh M
J Infect Dis; 2014 Apr; 209(8):1195-204. PubMed ID: 24368837
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Parainfluenza Virus Lower Respiratory Tract Disease after Hematopoietic Cell Transplantation.
Seo S; Xie H; Leisenring WM; Kuypers JM; Sahoo FT; Goyal S; Kimball LE; Campbell AP; Jerome KR; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2019 Jan; 25(1):163-171. PubMed ID: 30149147
[TBL] [Abstract][Full Text] [Related]
18. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.
Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR
Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes.
Waghmare A; Campbell AP; Xie H; Seo S; Kuypers J; Leisenring W; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2013 Dec; 57(12):1731-41. PubMed ID: 24065324
[TBL] [Abstract][Full Text] [Related]
20. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.
Renaud C; Xie H; Seo S; Kuypers J; Cent A; Corey L; Leisenring W; Boeckh M; Englund JA
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1220-6. PubMed ID: 23680472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
